The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical prostatectomy (RP).status: publishe
grantor: University of TorontoPrevious studies have demonstrated large age-based variation...
Survival after surgical treatment using competing-risk analysis has been previously examined in pati...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
PURPOSE: To investigate the prognostic impact of the Charlson comorbidity index (CCI) on either canc...
PURPOSE:Prostate cancer (PC) is a devastating and heterogeneous condition with diverse treatment opt...
PURPOSE: Prostate cancer (PC) is a devastating and heterogeneous condition with diverse treatment op...
PURPOSE: We investigated the long-term prognostic impact of age-adjusted Charlson comorbidity index ...
A multicenter Korean Prostate Cancer Database (K-CaP) has been established to provide information re...
Background:The value of radical prostatectomy (RP) as an approach for very high-risk prostate cancer...
In patients with a long life expectancy with high-risk (HR) prostate cancer (PCa), the chance to die...
PURPOSE: To analyze overall survival (OS), prostate cancer (PCa)-specific survival (PCaSS), and non-...
Background: Life expectancy is very essential in deciding treatment options in men with prostate can...
BACKGROUND: The value of radical prostatectomy (RP) as an approach for very high-risk prostate cance...
Background: Assess early oncological and functional outcomes following radical treatment of men with...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
grantor: University of TorontoPrevious studies have demonstrated large age-based variation...
Survival after surgical treatment using competing-risk analysis has been previously examined in pati...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
PURPOSE: To investigate the prognostic impact of the Charlson comorbidity index (CCI) on either canc...
PURPOSE:Prostate cancer (PC) is a devastating and heterogeneous condition with diverse treatment opt...
PURPOSE: Prostate cancer (PC) is a devastating and heterogeneous condition with diverse treatment op...
PURPOSE: We investigated the long-term prognostic impact of age-adjusted Charlson comorbidity index ...
A multicenter Korean Prostate Cancer Database (K-CaP) has been established to provide information re...
Background:The value of radical prostatectomy (RP) as an approach for very high-risk prostate cancer...
In patients with a long life expectancy with high-risk (HR) prostate cancer (PCa), the chance to die...
PURPOSE: To analyze overall survival (OS), prostate cancer (PCa)-specific survival (PCaSS), and non-...
Background: Life expectancy is very essential in deciding treatment options in men with prostate can...
BACKGROUND: The value of radical prostatectomy (RP) as an approach for very high-risk prostate cance...
Background: Assess early oncological and functional outcomes following radical treatment of men with...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
grantor: University of TorontoPrevious studies have demonstrated large age-based variation...
Survival after surgical treatment using competing-risk analysis has been previously examined in pati...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...